• About Us
• R&D Platform
• Pipelines
• News
• Contact Us
• Join Us

CN

• About Us
• R&D Platform
• Pipelines
• News
• Contact Us
• Join Us

CN

• About Us
• R&D Platform
• Pipelines
• News
• Contact Us
• Join Us
• CN

Unlimited innovation to change life.

-->

R&D Platform

   

Pipelines

   

News

• 2024/03/29

  Hopstem Biotechnology Received FDA Clearance of IND Application for hNPC01 in Chronic Ischemic Stroke

• 2023/06/21

  The iPSC-derived Human Forebrain Neural Progenitor Cell Injection hNPC01 of Hopstem has Received CDE's Clinical Implication Approval

• 2023/05/25

  The launch meeting of the clinical research project of Hopstem hNPC01 universal cell therapy product for the treatment of stroke sequelae was successfully held.

• 2023/05/25

  Good news! Hopstem has been awarded as one of the "Top 10 Organoid Enterprises with the Most Investment Value"!

• 2023/05/08

  Hopstem has honored to list on the “2023 Top 100 Future Healthcare List”

Join the leader of iPSC Cell Therapy！

More

Tel：0571-88197776 Email：info@hopstem.com

R&D Center: Building 11,Heda Medicine Valley V, Qiantang Area,
Hangzhou, Zhejiang, China

Manufacturing Center: 3rd & 4th Floor, Building 10,Heda Medicine Valley lll,
Qiantang Area, Hangzhou, Zhejiang, China

U.S. Office: 103 Carnegie center, Suite 300, Princeton,
NJ 08540, USA

• About Us
• R&D Platform
• Pipelines
• News
• Contact Us
• Join Us

© 2019 Hopstem Biotechnology Inc. ALL Rights reserved. 浙ICP备19021258号 Design by Eastdays

• 首页
• 咨询电话
• 返回顶部

XML 地图